Cargando…

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”

CD44 has been considered as a cancer stem cell marker in various tumors. With great enthusiasm, we read an article written by Wu et al. entitled “Expression of CD44 and the survival in glioma: a meta-analysis” published in Bioscience Reports. The authors performed meta-analyses to study the prognost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Chongxian, Lin, Han, Wang, Peng, Yang, Yong, Cen, Siyi, Zhou, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593535/ https://www.ncbi.nlm.nih.gov/pubmed/33030522 http://dx.doi.org/10.1042/BSR20202812

Ejemplares similares

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level
por: Klank, Rebecca L., et al.
Publicado: (2017)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

CD44‐associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage
por: Liu, Wei‐Hsiu, et al.
Publicado: (2019)

CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022)

CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma
por: Nishikawa, Masahiro, et al.
Publicado: (2021)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer
por: Zhang, Mei, et al.
Publicado: (2020)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrity
por: Ramos, Erika K, et al.
Publicado: (2022)

Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer
por: Lin, Neng-Yu, et al.
Publicado: (2023)

ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC
por: Kamarajan, Pachiyappan, et al.
Publicado: (2013)

Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
por: Chen, Peng, et al.
Publicado: (2020)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

TGF-β reduces DNA ds-break repair mechanisms to heighten genetic diversity and adaptability of CD44+/CD24− cancer cells
por: Pal, Debjani, et al.
Publicado: (2017)

GALNT2 sustains glioma stem cells by promoting CD44 expression
por: Liu, Yingying, et al.
Publicado: (2023)

Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)
por: Dubey, Parul, et al.
Publicado: (2022)

CD44v9 is associated with epithelial‐mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma
por: Taniguchi, Daisuke, et al.
Publicado: (2018)

CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line
por: Asai, Ryoma, et al.
Publicado: (2019)

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival
por: Näsman, Anders, et al.
Publicado: (2013)

SALL4 ‐ KHDRBS3 network enhances stemness by modulating CD44 splicing in basal‐like breast cancer
por: Matsumoto, Yoshiaki, et al.
Publicado: (2018)

Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta‐analysis
por: Feng, Yuan, et al.
Publicado: (2019)

Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis
por: Du, Zhanxin, et al.
Publicado: (2022)

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
por: Peng, Rui, et al.
Publicado: (2018)

Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas
por: Zhou, Ding, et al.
Publicado: (2021)

CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma
por: YIN, QIANG, et al.
Publicado: (2016)

A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro
por: Chen, Yujin, et al.
Publicado: (2018)

Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up‐regulation and increased apoptosis resistance upon vemurafenib treatment
por: Weitzenböck, Hans Peter, et al.
Publicado: (2021)

Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer
por: Gotoda, Takuji, et al.
Publicado: (1998)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
por: Yan, Xuefei, et al.
Publicado: (2019)

CD44 (+) cells determine fenofibrate‐induced microevolution of drug‐resistance in prostate cancer cell populations
por: Wróbel, Tomasz, et al.
Publicado: (2020)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Identification of glioma-associated antigen MUC 2-63 as CD44.
por: Romeijn, P., et al.
Publicado: (1994)

Prognostic significance of lncRNA DANCR expression in human cancers: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2021)

Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer
por: Lv, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5g739ad1gm0pbd8bjs3unvm079